This document discusses guidelines for managing hypertension in patients with stroke. It defines hypertension and classifies it based on stages and etiology. For patients with acute stroke, the guidelines recommend controlling blood pressure within certain ranges to balance risks of further stroke, rebleeding, and maintaining cerebral perfusion. For ischemic stroke patients, blood pressure should be lowered if significantly elevated. For intracerebral hemorrhage, blood pressure needs to be carefully controlled to reduce risks. For subarachnoid hemorrhage from aneurysm, blood pressure control can help prevent rebleeding until the aneurysm is treated. Choice of antihypertensive medications should consider the patient's condition and comorbidities.
Hypertensive crisis refers to severely elevated blood pressure that can lead to organ damage and is categorized as hypertensive urgency or emergency depending on the presence of end-organ damage; treatment of urgency involves gradual oral medication while emergency requires immediate intravenous drugs to reduce blood pressure to prevent further damage; careful diagnosis and monitoring of blood pressure and organs is needed along with selecting appropriate drugs based on the situation.
This document defines hypertensive crises and hypertensive encephalopathy. It distinguishes between hypertensive urgency, which is elevated blood pressure without end organ damage, and hypertensive emergency, which is elevated blood pressure with end organ damage. Hypertensive encephalopathy is specifically defined as abrupt elevated blood pressure exceeding cerebral autoregulation limits, causing headaches, confusion, and other neurological symptoms. The pathophysiology involves failure of cerebral blood flow regulation and damage to blood vessels from very high blood pressure. Treatment of hypertensive urgency can be done with oral antihypertensives over 1-2 days, while hypertensive emergency requires rapid parenteral treatment to lower diastolic blood pressure by 25%
This document discusses hypertension and its relationship to stroke. It covers several key points:
1. Hypertension is a major risk factor for stroke, responsible for 10% of deaths in India, with 51% of stroke deaths due to hypertension. Both systolic and diastolic blood pressure are strongly correlated with stroke risk.
2. Acute blood pressure management in ischemic stroke is complex, as both extreme hypertension and induced hypotension can be detrimental by disrupting cerebral blood flow. Moderate control to less than 220/120 mmHg is recommended when possible.
3. In intracerebral hemorrhage, elevated blood pressure increases hematoma expansion risk in the first hours, so aggressive control to less
This document outlines the presentation and management of a talk on hypertensive emergencies. It defines hypertensive emergencies as severe elevations in blood pressure with evidence of end organ damage. The goals are to gradually lower blood pressure by 10-20% in the first hour and further 5-15% over 24 hours, to a target of <180/<120 mmHg initially and <160/<110 mmHg thereafter. Management depends on the specific end organ involved and may require additional interventions like thrombolysis. Close follow up is needed after discharge to prevent recurrence through treatment of underlying causes and management of blood pressure long term.
This document discusses the evaluation, diagnosis, and management of severe hypertension. It defines different types of severe hypertension including hypertensive urgency, hypertensive emergency, resistant hypertension, and refractory hypertension. It provides details on clinical presentation, diagnostic tests, rate of blood pressure reduction, outpatient versus inpatient management, and intravenous antihypertensive medications. The goal is to lower blood pressure slowly over hours to days to reduce risks of end-organ damage while also addressing any underlying causes of treatment-resistant hypertension.
The presentation covers definitions, identification, Treatment goals, Special situations, Practice points, and cardinal pharmacotherapy. Session presented in NBE learning session
Mr. A is a 61-year-old retired police officer who presented with headache and giddiness. His blood pressure was 150/90 mmHg. Tests showed grade 1 hypertension, obesity, impaired glucose tolerance, and dyslipidemia. He has a high cardiovascular risk level. An ACE inhibitor would be an appropriate initial treatment to aim for a target blood pressure of below 140/90 mmHg. Appropriate response would be a reduction in blood pressure of at least 25% over 24 hours without going below 160/90 mmHg. Hypertensive emergencies require rapid blood pressure reduction of 25% over 3-12 hours while monitoring for specific organ involvement.
Ambulatory blood pressure monitoring (ABPM) provides important information about a patient's blood pressure over 24 hours. It can identify white coat hypertension, masked hypertension, nocturnal hypertension, and determine if a patient's blood pressure demonstrates the normal dipping pattern. ABPM is useful for diagnosing hypertension more accurately and guiding treatment decisions, as it considers factors like blood pressure load and variability that may be missed by office readings alone.
Hypertensive crisis refers to severely elevated blood pressure that can lead to organ damage and is categorized as hypertensive urgency or emergency depending on the presence of end-organ damage; treatment of urgency involves gradual oral medication while emergency requires immediate intravenous drugs to reduce blood pressure to prevent further damage; careful diagnosis and monitoring of blood pressure and organs is needed along with selecting appropriate drugs based on the situation.
This document defines hypertensive crises and hypertensive encephalopathy. It distinguishes between hypertensive urgency, which is elevated blood pressure without end organ damage, and hypertensive emergency, which is elevated blood pressure with end organ damage. Hypertensive encephalopathy is specifically defined as abrupt elevated blood pressure exceeding cerebral autoregulation limits, causing headaches, confusion, and other neurological symptoms. The pathophysiology involves failure of cerebral blood flow regulation and damage to blood vessels from very high blood pressure. Treatment of hypertensive urgency can be done with oral antihypertensives over 1-2 days, while hypertensive emergency requires rapid parenteral treatment to lower diastolic blood pressure by 25%
This document discusses hypertension and its relationship to stroke. It covers several key points:
1. Hypertension is a major risk factor for stroke, responsible for 10% of deaths in India, with 51% of stroke deaths due to hypertension. Both systolic and diastolic blood pressure are strongly correlated with stroke risk.
2. Acute blood pressure management in ischemic stroke is complex, as both extreme hypertension and induced hypotension can be detrimental by disrupting cerebral blood flow. Moderate control to less than 220/120 mmHg is recommended when possible.
3. In intracerebral hemorrhage, elevated blood pressure increases hematoma expansion risk in the first hours, so aggressive control to less
This document outlines the presentation and management of a talk on hypertensive emergencies. It defines hypertensive emergencies as severe elevations in blood pressure with evidence of end organ damage. The goals are to gradually lower blood pressure by 10-20% in the first hour and further 5-15% over 24 hours, to a target of <180/<120 mmHg initially and <160/<110 mmHg thereafter. Management depends on the specific end organ involved and may require additional interventions like thrombolysis. Close follow up is needed after discharge to prevent recurrence through treatment of underlying causes and management of blood pressure long term.
This document discusses the evaluation, diagnosis, and management of severe hypertension. It defines different types of severe hypertension including hypertensive urgency, hypertensive emergency, resistant hypertension, and refractory hypertension. It provides details on clinical presentation, diagnostic tests, rate of blood pressure reduction, outpatient versus inpatient management, and intravenous antihypertensive medications. The goal is to lower blood pressure slowly over hours to days to reduce risks of end-organ damage while also addressing any underlying causes of treatment-resistant hypertension.
The presentation covers definitions, identification, Treatment goals, Special situations, Practice points, and cardinal pharmacotherapy. Session presented in NBE learning session
Mr. A is a 61-year-old retired police officer who presented with headache and giddiness. His blood pressure was 150/90 mmHg. Tests showed grade 1 hypertension, obesity, impaired glucose tolerance, and dyslipidemia. He has a high cardiovascular risk level. An ACE inhibitor would be an appropriate initial treatment to aim for a target blood pressure of below 140/90 mmHg. Appropriate response would be a reduction in blood pressure of at least 25% over 24 hours without going below 160/90 mmHg. Hypertensive emergencies require rapid blood pressure reduction of 25% over 3-12 hours while monitoring for specific organ involvement.
Ambulatory blood pressure monitoring (ABPM) provides important information about a patient's blood pressure over 24 hours. It can identify white coat hypertension, masked hypertension, nocturnal hypertension, and determine if a patient's blood pressure demonstrates the normal dipping pattern. ABPM is useful for diagnosing hypertension more accurately and guiding treatment decisions, as it considers factors like blood pressure load and variability that may be missed by office readings alone.
This document summarizes guidelines for the treatment of hypertension based on the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. It defines hypertension and stages of high blood pressure. Lifestyle modifications and drug therapies are recommended, with treatment guided by blood pressure level and risk factors. Initial drug choices include thiazide diuretics, with addition of ACE inhibitors, ARBs, beta blockers, or calcium channel blockers as needed to control blood pressure. Special patient groups benefit from specific drug classes due to compelling indications.
A presentation hypertension
(what blood pressure is, what is hypertension, what are the risk factors of hypertension, how is it managed?) and other related knowledge on hypertension
The document discusses hypertensive emergencies, which are severe hypertension with acute impairment of an organ system. It defines different categories of hypertension and provides case examples. It covers the etiology, pathophysiology, symptoms, workup, and treatment of hypertensive emergencies. Treatment involves rapidly lowering blood pressure over minutes to hours for patients with end-organ damage, while those without can have blood pressure controlled over days to weeks. Intravenous medications like nitroprusside, labetalol, and nicardipine are used for rapid blood pressure reduction in emergencies.
Perioperative case of myocardial ischemia and its management ZIKRULLAH MALLICK
This document describes the case of a 40-year-old male patient who experienced hypotension, bradycardia, and ST segment changes during a long orthopedic surgery, indicating possible acute coronary syndrome. Biomarkers after surgery confirmed myocardial injury. The patient was treated in the ICU and recovered. The document then reviews risk factors, mechanisms, diagnosis, and management of perioperative myocardial infarction.
This document summarizes a seminar presentation on hypertension given by two nursing students. It began with an outline and objectives. The students then defined hypertension and discussed blood pressure classifications. They explained determinants of blood pressure and risk factors for primary hypertension. Clinical manifestations, complications, and types of hypertension such as primary, secondary, and hypertensive crisis were summarized. The students concluded by discussing diagnostic evaluation, management through lifestyle modifications and pharmacological treatments, and the stepwise algorithm for hypertension management.
Clevidipine is an intravenous calcium channel blocker approved by the FDA in 2008 for the management of acute, severe hypertension. It has a short half-life of 1-2 minutes and quick onset and offset of action. Studies have shown clevidipine to be effective in treating both preoperative and postoperative hypertension in cardiac surgery patients, with blood pressure control similar to other intravenous antihypertensives like nitroprusside, nitroglycerin, and nicardipine. Clevidipine lowers systemic vascular resistance and has greater effects on arterial vasodilation compared to other agents.
This document discusses hypertensive emergencies and urgencies. It defines hypertensive emergency as severe hypertension with acute end-organ damage, requiring rapid BP reduction over hours. Hypertensive urgency is severe hypertension without acute end-organ damage, allowing BP control over days to weeks. The main organs affected are the brain, heart, and kidneys. Initial treatment involves evaluating for end-organ damage and relaxing the patient before considering IV antihypertensives. Goals are to lower BP by 25% over the first hour while maintaining organ perfusion. Specific treatments depend on the damaged organ system. Follow-up after discharge assesses for ongoing hypertension management.
hypertension anesthesia, general management. antihypertensive pharmacologyAbayneh Belihun
This document outlines a presentation on hypertension given at Aksum University in February 2016. It discusses the significance of hypertension for anesthetists, including how familiarity with antihypertensive drugs is important. It also notes that hypertension commonly occurs during anesthesia and its recognition depends on correctly functioning monitors. The document provides definitions of hypertension and outlines its classification, as well as general management approaches including non-pharmacological and pharmacological treatment. It discusses various drug classes used to treat hypertension and their mechanisms of action.
This document provides an overview of hypertension including its epidemiology, pathophysiology, risk factors, signs and symptoms, classification, diagnosis, management, and lifestyle modifications. It discusses how both systolic and diastolic blood pressure increase cardiovascular risk. The presentation also reviews the revised definitions of hypertension in American and European guidelines, drug treatment recommendations including initial use of fixed-dose combinations, and potential increased cancer risk with hydrochlorothiazide.
1) Ambulatory blood pressure monitoring (ABPM) involves measuring blood pressure at regular intervals over 24 hours while patients go about normal daily activities. This provides a more accurate estimate of true blood pressure than isolated clinic readings.
2) ABPM is useful for diagnosing white-coat hypertension, masked hypertension, nocturnal hypertension, and treatment-resistant hypertension. It can help guide antihypertensive treatment.
3) Classification based on ABPM includes white-coat hypertension, masked hypertension, and nocturnal hypertension patterns. ABPM is endorsed in clinical guidelines and is the gold standard for predicting cardiovascular risk related to blood pressure.
Hypertension, or high blood pressure, is defined as a systolic blood pressure over 140 mm Hg or a diastolic blood pressure over 90 mm Hg. It can be caused by primary or secondary factors and is a major risk factor for cardiovascular disease. Treatment involves lifestyle modifications like diet, exercise, and weight loss as well as pharmacological therapies including diuretics, ACE inhibitors, calcium channel blockers, and others. Management may differ in special populations such as pregnant women, children, the elderly, and those with diabetes or kidney disease.
This document discusses hypertension (high blood pressure). It defines hypertension as a systolic blood pressure over 140 mm Hg or a diastolic over 90 mm Hg. It classifies blood pressure levels and discusses the causes, risk factors, diagnosis, and management of hypertension through lifestyle modifications and pharmacological treatments. Specific populations discussed include those with diabetes, pregnancy, children, emergencies, and geriatrics. The goal is to treat hypertension to reduce risks of heart disease and stroke through safe and effective medical care.
The document discusses hypertension (HTN), defining its stages and types. Isolated systolic HTN mainly affects those over 55 and can be caused by increased cardiac output or stroke volume. Treatment of reversible risk factors can prevent HTN development and cardiovascular disease. The major risk factor is coronary artery disease. Secondary HTN accounts for 5-15% of cases and is commonly due to renal or renovascular disease. Refractory HTN may be caused by poor adherence, secondary HTN, or hyperaldosteronism. Screening those at risk every 6-12 months can help prevent HTN.
The document discusses hypertension including its definition, types, symptoms, risk factors, pathophysiology, classifications, causes, complications, and treatment. It defines normal and abnormal blood pressure values and classifications. It describes primary and secondary hypertension and their causes. Untreated hypertension can damage the heart, kidneys, retina and brain. Treatment includes lifestyle modifications like diet, exercise, and weight loss as well as pharmacological therapies targeting the renin-angiotensin-aldosterone system.
This document discusses hypertension (high blood pressure). It defines hypertension and normal blood pressure readings. It covers the objectives of understanding hypertension, classifying blood pressure levels, identifying causes, measuring blood pressure appropriately, recommending lifestyle modifications and medications for treatment, and constructing monitoring plans. Risk factors for hypertension include age, family history, obesity, smoking, and more. Long-term complications if untreated include damage to organs like the brain, eyes, heart and kidneys. Treatment involves lifestyle changes and medications to control blood pressure and reduce risks of health problems.
This document discusses hypertensive crises, including definitions, epidemiology, pathophysiology, assessment, diagnosis, and management. It defines hypertensive emergencies as elevated blood pressure with acute end-organ damage, while hypertensive urgencies involve impending end-organ damage. The typical patient presenting with crisis is middle-aged, noncompliant with medications, and may use substances. Treatment of emergencies requires immediate blood pressure reduction in the ICU to prevent further damage, while urgencies can be treated gradually as uncontrolled hypertension. Nitroprusside is very effective but has limitations like toxicity risks with prolonged use.
This document summarizes guidelines for the treatment of hypertension based on the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. It defines hypertension and stages of high blood pressure. Lifestyle modifications and drug therapies are recommended, with treatment guided by blood pressure level and risk factors. Initial drug choices include thiazide diuretics, with addition of ACE inhibitors, ARBs, beta blockers, or calcium channel blockers as needed to control blood pressure. Special patient groups benefit from specific drug classes due to compelling indications.
A presentation hypertension
(what blood pressure is, what is hypertension, what are the risk factors of hypertension, how is it managed?) and other related knowledge on hypertension
The document discusses hypertensive emergencies, which are severe hypertension with acute impairment of an organ system. It defines different categories of hypertension and provides case examples. It covers the etiology, pathophysiology, symptoms, workup, and treatment of hypertensive emergencies. Treatment involves rapidly lowering blood pressure over minutes to hours for patients with end-organ damage, while those without can have blood pressure controlled over days to weeks. Intravenous medications like nitroprusside, labetalol, and nicardipine are used for rapid blood pressure reduction in emergencies.
Perioperative case of myocardial ischemia and its management ZIKRULLAH MALLICK
This document describes the case of a 40-year-old male patient who experienced hypotension, bradycardia, and ST segment changes during a long orthopedic surgery, indicating possible acute coronary syndrome. Biomarkers after surgery confirmed myocardial injury. The patient was treated in the ICU and recovered. The document then reviews risk factors, mechanisms, diagnosis, and management of perioperative myocardial infarction.
This document summarizes a seminar presentation on hypertension given by two nursing students. It began with an outline and objectives. The students then defined hypertension and discussed blood pressure classifications. They explained determinants of blood pressure and risk factors for primary hypertension. Clinical manifestations, complications, and types of hypertension such as primary, secondary, and hypertensive crisis were summarized. The students concluded by discussing diagnostic evaluation, management through lifestyle modifications and pharmacological treatments, and the stepwise algorithm for hypertension management.
Clevidipine is an intravenous calcium channel blocker approved by the FDA in 2008 for the management of acute, severe hypertension. It has a short half-life of 1-2 minutes and quick onset and offset of action. Studies have shown clevidipine to be effective in treating both preoperative and postoperative hypertension in cardiac surgery patients, with blood pressure control similar to other intravenous antihypertensives like nitroprusside, nitroglycerin, and nicardipine. Clevidipine lowers systemic vascular resistance and has greater effects on arterial vasodilation compared to other agents.
This document discusses hypertensive emergencies and urgencies. It defines hypertensive emergency as severe hypertension with acute end-organ damage, requiring rapid BP reduction over hours. Hypertensive urgency is severe hypertension without acute end-organ damage, allowing BP control over days to weeks. The main organs affected are the brain, heart, and kidneys. Initial treatment involves evaluating for end-organ damage and relaxing the patient before considering IV antihypertensives. Goals are to lower BP by 25% over the first hour while maintaining organ perfusion. Specific treatments depend on the damaged organ system. Follow-up after discharge assesses for ongoing hypertension management.
hypertension anesthesia, general management. antihypertensive pharmacologyAbayneh Belihun
This document outlines a presentation on hypertension given at Aksum University in February 2016. It discusses the significance of hypertension for anesthetists, including how familiarity with antihypertensive drugs is important. It also notes that hypertension commonly occurs during anesthesia and its recognition depends on correctly functioning monitors. The document provides definitions of hypertension and outlines its classification, as well as general management approaches including non-pharmacological and pharmacological treatment. It discusses various drug classes used to treat hypertension and their mechanisms of action.
This document provides an overview of hypertension including its epidemiology, pathophysiology, risk factors, signs and symptoms, classification, diagnosis, management, and lifestyle modifications. It discusses how both systolic and diastolic blood pressure increase cardiovascular risk. The presentation also reviews the revised definitions of hypertension in American and European guidelines, drug treatment recommendations including initial use of fixed-dose combinations, and potential increased cancer risk with hydrochlorothiazide.
1) Ambulatory blood pressure monitoring (ABPM) involves measuring blood pressure at regular intervals over 24 hours while patients go about normal daily activities. This provides a more accurate estimate of true blood pressure than isolated clinic readings.
2) ABPM is useful for diagnosing white-coat hypertension, masked hypertension, nocturnal hypertension, and treatment-resistant hypertension. It can help guide antihypertensive treatment.
3) Classification based on ABPM includes white-coat hypertension, masked hypertension, and nocturnal hypertension patterns. ABPM is endorsed in clinical guidelines and is the gold standard for predicting cardiovascular risk related to blood pressure.
Hypertension, or high blood pressure, is defined as a systolic blood pressure over 140 mm Hg or a diastolic blood pressure over 90 mm Hg. It can be caused by primary or secondary factors and is a major risk factor for cardiovascular disease. Treatment involves lifestyle modifications like diet, exercise, and weight loss as well as pharmacological therapies including diuretics, ACE inhibitors, calcium channel blockers, and others. Management may differ in special populations such as pregnant women, children, the elderly, and those with diabetes or kidney disease.
This document discusses hypertension (high blood pressure). It defines hypertension as a systolic blood pressure over 140 mm Hg or a diastolic over 90 mm Hg. It classifies blood pressure levels and discusses the causes, risk factors, diagnosis, and management of hypertension through lifestyle modifications and pharmacological treatments. Specific populations discussed include those with diabetes, pregnancy, children, emergencies, and geriatrics. The goal is to treat hypertension to reduce risks of heart disease and stroke through safe and effective medical care.
The document discusses hypertension (HTN), defining its stages and types. Isolated systolic HTN mainly affects those over 55 and can be caused by increased cardiac output or stroke volume. Treatment of reversible risk factors can prevent HTN development and cardiovascular disease. The major risk factor is coronary artery disease. Secondary HTN accounts for 5-15% of cases and is commonly due to renal or renovascular disease. Refractory HTN may be caused by poor adherence, secondary HTN, or hyperaldosteronism. Screening those at risk every 6-12 months can help prevent HTN.
The document discusses hypertension including its definition, types, symptoms, risk factors, pathophysiology, classifications, causes, complications, and treatment. It defines normal and abnormal blood pressure values and classifications. It describes primary and secondary hypertension and their causes. Untreated hypertension can damage the heart, kidneys, retina and brain. Treatment includes lifestyle modifications like diet, exercise, and weight loss as well as pharmacological therapies targeting the renin-angiotensin-aldosterone system.
This document discusses hypertension (high blood pressure). It defines hypertension and normal blood pressure readings. It covers the objectives of understanding hypertension, classifying blood pressure levels, identifying causes, measuring blood pressure appropriately, recommending lifestyle modifications and medications for treatment, and constructing monitoring plans. Risk factors for hypertension include age, family history, obesity, smoking, and more. Long-term complications if untreated include damage to organs like the brain, eyes, heart and kidneys. Treatment involves lifestyle changes and medications to control blood pressure and reduce risks of health problems.
This document discusses hypertensive crises, including definitions, epidemiology, pathophysiology, assessment, diagnosis, and management. It defines hypertensive emergencies as elevated blood pressure with acute end-organ damage, while hypertensive urgencies involve impending end-organ damage. The typical patient presenting with crisis is middle-aged, noncompliant with medications, and may use substances. Treatment of emergencies requires immediate blood pressure reduction in the ICU to prevent further damage, while urgencies can be treated gradually as uncontrolled hypertension. Nitroprusside is very effective but has limitations like toxicity risks with prolonged use.
Similar to TATALAKSANA HIPERTENSI PADA PASIEN STROKE.pptx (20)
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
2. DEFINISI
Hipertensi adalah bila TDS ≥140
mmHg dan/atau TDD ≥90
mmHg pada pengukuran di
klinik atau fasilitas layanan
kesehatan.1
Hypertension is defined as a
systolic blood pressure (SBP) of
140 mm Hg or more, or a
diastolic blood pressure (DBP) of
90 mm Hg or more, or taking
antihypertensive medication.2
1Kosasih adrianus et al. consensus penatalksanaan hipertensi 2019. perhimpunan dokter hipertensi Indonesia
2Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure. Hypertension. 2003 Dec. 42(6):1206-52.
3. DEFINISI
JNC VII 2003. ESH-ESC 2013. NICE 2011
Tekanan darah sistol ≥ 140 mmHg ATAU
Tekanan darah diastol ≥ 90 mmHg
Umur > 18 tahun
Tidak menggunakan obat anti hipertensi
10. CLASSIFICATION
1Chopra HK et al: Recent Guidelines for Hypertension. Circulation Research. 2019;124:984–986 At https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.119.314789
11. OTHER TERMINOLOGY
Terminology
Resistant
hypertension:
blood pressure above goal despite adherence to a combination of at least
3 optimally dosed antihypertensive medications with different
mechanisms of action.1
Refractory
hypertension:
blood pressure above goal despite adherence to a combination of at least
5 optimally dosed antihypertensive medications with different
mechanisms of action including spironolactone.1
Hypertensive urgency a subset of hypertensive crises, are characterized by acute, severe
elevations in blood pressure, often greater than 180/110 mm Hg (typically
with systolic blood pressure [SBP] greater than 200 mm Hg and/or
diastolic blood pressure [DBP] greater than 120 mm Hg) but are not
associated with target-organ dysfunction.2
Hypertensive
emergency
a subset of hypertensive crises, are characterized by acute, severe
elevations in blood pressure, often greater than 180/110 mm Hg (typically
with systolic blood pressure [SBP] greater than 200 mm Hg and/or
diastolic blood pressure [DBP] greater than 120 mm Hg) associated with
the presence or impendence of target-organ dysfunction2
1. Scott at al. Hypertension Emergencies. CCSAP
2Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure. Hypertension. 2003 Dec. 42(6):1206-52.
12. OTHER TERMINOLOGY
Terminology
White coat
hypertension:
refers to the untreated condition in which BP is elevated in the office, but
is normal when measured by ABPM, HBPM, or both.2
Masked hypertension refers to untreated patients in whom BP is normal in the office but is
elevated when measured by HBPM or ABPM2
Pseudo-resistant
hypertension
Individuals with elevated office BPs due to white-coat hypertension,
improper BP measurement or medication nonadherence do not have true
resistant hypertension but have so-called2
Pre-existing
hypertension
(hipertensi kronik)
Onset dimulai sebelum kehamilan atau sebelum minggu ke-20 kehamilan,
dan biasanya menetap selama lebih dari 6 minggu pasca persalinan dan
dapat disertai proteinuria.1
Hipertensi gestasional Terjadi setelah minggu ke-20 kehamilan dan biasanya membaik dalam 6
minggu pasca persalinan.1
Hipertensi kronik plus
superimposed
Ahipertensi gestasional dengan proteinuria1
1Kosasih adrianus et al. consensus penatalksanaan hipertensi 2019. perhimpunan dokter hipertensi Indonesia
2Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure. Hypertension. 2003 Dec. 42(6):1206-52.
13. TERMINOLOGY
Dubenbostel et al. Refractory Hypertension: A novel phenotype of antihypertensive treatment failure. Hypertension.2016 jun;67(6):1085-92
14. DEFINISI STROKE
Gejala defisit neurologis akut baik fokal atau global yang mendadak
Berkurangnya atau hilangnya aliran darah pada parenkim otak,
retina, atau medulla spinalis
Disebabkan penyumbatan atau pecahnya arteri atau vena (vaskular)
yang dibuktikan dengan imaging dan/atau patologi
19. PATOGENESIS STROKE ISKEMIK
Indikator Ischemic-
Core
Penumbra Luxury
Perfusion
Morfologi Sangat pucat Pucat Kemerahan
dan Edema
CBF Paling
rendah
Rendah Sangat tinggi
PO2 Rendah Rendah Tinggi
PCO2 Tinggi Tinggi
Asam Laktat Tinggi Meningkat
Neuron Degenerasi Functional
Paralysis
• Therapeutic Window Reversibilitas
neuron penumbra
• Tx : Resusitasi
• Iskemia berkepanjangan Apoptosis
24. MANAGEMEN STROKE
KEDARURATAN MEDIK STROKE AKUT:
TEKANAN DARAH (HIPOTENSI)
Hipotensi arterial berhubungan dengan buruknya keluaran
neurologis, terutama bila TDS < 100mmHg dan TDD <70mmHg
Harus dicari etiologi dan diatasi
Vasopresor (Fenileprin, dopamin, dan norepinefrin)
Diawali dengan dosis kecil dan dipertahankan pada TDS 140 mmHg
pada kondisi akut stroke
31. RISK FACTORS FOR AND PREVENTION OF ASAH RECOMMENDATIONS
31
Treatment of high blood pressure with antihypertensive medication is recommended
to prevent ischemic stroke, intracerebral hemorrhage, and cardiac, renal, and other
end-organ injury (Class I; Level of Evidence A).
Hypertension should be treated, and such treatment may reduce the risk of aSAH
(Class I; Level of Evidence B).
32. MEDICAL MEASURES TO PREVENT REBLEEDING AFTER ASAH
32
Between the time of aSAH symptom onset and aneurysm
obliteration, blood pressure should be controlled with a titratable
agent to balance the risk of stroke, hypertension-related
rebleeding, and maintenance of cerebral perfusion pressure
(Class I; Level of Evidence B). (New recommendation)
The magnitude of blood pressure control to reduce the risk of
rebleeding has not been established, but a decrease in systolic
blood pressure to <160 mm Hg is reasonable (Class IIa; Level of
Evidence C). (New recommendation)
Acute hypertension should be controlled after aSAH and until
aneurysm obliteration, but parameters for blood pressure control
have not been defined
33. MANAGEMEN STROKE
KEDARURATAN MEDIK STROKE AKUT: TEKANAN DARAH
(HIPERTENSI)
73,9% hipertensi dengan 22,5-27,6% memiliki TDS > 180mmHg
Iskemik
Diturunkan sekitar 15% dlm 24 jam pertama stlh onset apabila TDS > 220 mmHg
atau TDD > 120
Jika akan diberi rtPA, diturunkan hingga TDS <185 mmHg dan TDD < 110 mmHg
Setelah pemberian rtPA, harus dipantau hingga TDS < 180 dan TDD < 105 selama
24 jam pertama
Labetalol, nitroprusid, nikardipin.
Hemorragik Intraserebral
TDS > 200 atau MAP > 150, diturunkan dengan antihipertensi IV secara kontinu
dengan pemantauan setiap 5 menit
TDS 150 – 220, dapat diturunkan dengan cepat hingga 140 mmHg
Setelah kraniotomi, target MAP 100 mmHg
Hemoragik SAH Aneurisma
Diturunkan hingga TDS 140 – 160 untuk mencegah SAH berulang
Mencegah risiko vasospamse, target TDS 160-180 (tergantung usi, berat ringan
risiko, komorbiditas)
2Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec. 42(6):1206-52.
Lily S. L. 2016. “Hypertension”. Pathophysiology of heart disease 6th ed.Wolter kluwer
Hipotensi dan hypovolemia harus dikoreksi untuk mempertahankan tingkat perfusi sistemik
Pasien yang memiliki TD tinggi dan dinyatakan memenuhi syarat untuk pengobatan IV alteplase harus menurunkan TD (TD sistolok < 185mmgh dan TD diastolic <110mmhg) sebelum terapi IV fibrinolotik dimulai
Tekanan darah - alteplase IV direkomendasikan pada pasien dengan BP <185/110 mm Hg dan pada pasien yang BP dapat diturunkan dengan aman ke tingkat ini dengan agen antihipertensi, dengan dokter menilai stabilitas BP sebelum memulai IV alteplase.† ( COR I;LOE B-NR)§
Ukur TD dan lakukan penilaian neurologis setiap 15 menit selama dan setelah infus alteplase IV selama 2 jam, kemudian setiap 30 menit selama 6 jam, kemudian setiap jam hingga 24 jam setelah pengobatan alteplase IV.
Tingkatkan frekuensi pengukuran TD jika SBP >180 mmHg atau jika DBP >105 mmHg; berikan obat antihipertensi untuk mempertahankan tekanan darah pada atau di bawah level ini (Tabel 5).
Pilihan pengobatan TD:
Labetalol: 10-20mg IV selama 1-2 menit, mengulang x1
• Nicardipine: 5mg / jam IV, titrasi 2.5mg / jam setiap 5-15 menit (maks 15 mg / jam)
• Clevidipine: 1-2mg / jam IV, dosis ganda setiap 2-5 menittitrasi (maks 21 mg / jam)
Pada pasien yang menjalani trombektomi mekanis, perlu mempertahankan tekanan darah pada <180/105 mmHg selama dan selama 24 jam setelah prosedur
Pada pasien yang menjalani trombektomi mekanik dengan sukses reperfusi, mungkin masuk akal untuk mempertahankan tekanan darah pada tingkat <180/105 mmHg.
Hipotensi dan hipovolemia harus dikoreksi untuk mempertahankan tingkat perfusi sistemik yang diperlukan untuk mendukung fungsi organ.
Pada pasien dengan AIS, pengobatan dini hipertensi diindikasikan bila diperlukan oleh kondisi komorbiditas (misalnya, kejadian koroner akut bersamaan, gagal jantung akut, diseksi aorta, postfibrinolisis sICH, atau preeklampsia/eklampsia).
Pada pasien dengan BP >220/120 mmHg yang tidak menerima alteplase IV atau trombektomi mekanis dan tidak memiliki kondisi komorbiditas yang memerlukan pengobatan antihipertensi mendesak, manfaat memulai atau memulai kembali pengobatan hipertensi dalam 48 hingga 72 jam pertama tidak pasti. Mungkin masuk akal untuk menurunkan BP sebesar 15% selama 24 jam pertama setelah serangan stroke.
Pada pasien dengan BP <220/120 mmHg yang tidak menerima alteplase IV atau trombektomi mekanik dan tidak memiliki kondisi komorbiditas yang memerlukan pengobatan antihipertensi mendesak, memulai atau memulai kembali pengobatan hipertensi dalam 48 hingga 72 jam pertama setelah AIS tidak dianjurkan. efektif untuk mencegah kematian atau ketergantungan.
Rekomendasi Faktor Risiko dan Pencegahan SAH
Pengobatan tekanan darah tinggi dengan obat antihipertensi direkomendasikan untuk mencegah stroke iskemik, perdarahan intraserebral, dan cedera organ akhir jantung, ginjal, dan lainnya (Kelas I; Tingkat Bukti A).
Hipertensi harus diobati, dan pengobatan tersebut dapat mengurangi risiko SAH (Kelas I; Tingkat Bukti B).
Rekomendasi Tindakan Medis untuk Mencegah Pendarahan Ulang Setelah SAH
Antara waktu onset gejala SAH dan menghilangkan aneurisma, tekanan darah harus dikontrol dengan agen yang dapat dititrasi untuk menyeimbangkan risiko stroke, perdarahan ulang terkait hipertensi, dan pengendalian tekanan perfusi serebral (Kelas I; Tingkat Bukti B). (Rekomendasi baru)
Besarnya kontrol tekanan darah untuk mengurangi risiko perdarahan ulang belum ditetapkan, namun penurunan tekanan darah sistolik hingga <160 mm Hg masuk akal (Kelas IIa; Tingkat Bukti C). (Rekomendasi baru.